PROSTATE CANCER METASTATIC DISEASE
Clinical trials for PROSTATE CANCER METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation added to hormone therapy could extend control of advanced prostate cancer
Disease control Recruiting nowThis study is testing if adding targeted radiation to standard hormone therapy helps control advanced prostate cancer for a longer time. It will include about 192 men newly diagnosed with prostate cancer that has spread. After initial hormone therapy, doctors will use a special s…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill tested for men with Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HLD-0915 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies. The main goals are to find a safe dose and see if the drug can help control the cancer. The stu…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Can a special diet and walking plan protect hearts of men battling prostate cancer?
Disease control Recruiting nowThis study is testing whether a specific low-calorie, anti-inflammatory diet combined with regular walking can help reduce body fat and improve heart health markers in men with advanced prostate cancer who are on hormone therapy. It will compare how 70 men—35 African American and…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New scan could spot spreading prostate cancer more clearly
Diagnosis Recruiting nowThis study is testing a new type of imaging scan to see if it can better detect and track prostate cancer that has spread. Researchers want to compare this new scan to the current standard scan to see which is more accurate. About 30 men with prostate cancer will get both types o…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Glowing dye could help surgeons spot hidden prostate cancer
Diagnosis Recruiting nowThis study is testing whether a special fluorescent dye called Zopocianine (OTL78) can help surgeons better see prostate cancer cells during surgery. The dye is designed to stick to prostate cancer cells and glow under special near-infrared light, potentially helping surgeons rem…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC
-
New scan could spot prostate Cancer's return sooner
Diagnosis Recruiting nowThis study is testing if adding a special scan called a PSMA PET to the usual MRI can better detect if prostate cancer returns in men who have had focal therapy. Researchers will follow 62 men for about a year after their treatment to compare how well the two scans find returning…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Mar 23, 2026 15:15 UTC
-
New hope for men suffering debilitating hot flashes from cancer treatment
Symptom relief Recruiting nowThis study is testing whether a medication called fezolinetant can safely reduce the frequency and severity of hot flashes in men with prostate cancer who are undergoing hormone-blocking therapy. Researchers will compare the drug to a placebo in 60 participants over 4 weeks to se…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Cheaper scan could track deadly prostate cancer
Knowledge-focused Recruiting nowThis study aims to see if a simpler, more widely available type of scan (called SPECT/CT) can effectively monitor how well a targeted radiation treatment is working for men with advanced prostate cancer. Researchers will compare this simpler scan to a more expensive and complex s…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC